Red
Brand Name(s):Viekirax
Indication:Hepatitis C – Chronic (CHC) & virus (HCV)
Rationale:1,2,3
Considered:Feb-15
Review Date:Jan-26
Comments:
MHRA Recommend INR monitoring secondary to treatment. 2017
MHRA Recommend screening for Hepatitis B before starting treatment 2017
MHRA state rapid reducion in hepatitis C viral load can affect glucose metabolism in patients with Diabetes 2018
NICE technology appraisal guidance [TA365]
Ombitasvirâparitaprevirâritonavir with or without dasabuvir for treating chronic hepatitis C
Full document can be found at: http://www.nice.org.uk/guidance/ta365
November 2015